N-[1-[(E)-4-[5-carbamoyl-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-7-(3-hydroxypropoxy)benzimidazol-1-yl]but-2-enyl]-5-[(dimethylamino)methyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide
C40H48N10O8 — CID 155786918
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[(E)-4-[5-carbamoyl-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-7-(3-hydroxypropoxy)benzimidazol-1-yl]but-2-enyl]-5-[(dimethylamino)methyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide
N-[1-[(E)-4-[5-carbamoyl-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-7-(3-hydroxypropoxy)benzimidazol-1-yl]but-2-enyl]-5-[(dimethylamino)methyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide (PubChem CID 155786918) has the molecular formula C40H48N10O8 and a molecular weight of 796.89 g/mol. Its IUPAC name is N-[1-[(E)-4-[5-carbamoyl-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-7-(3-hydroxypropoxy)benzimidazol-1-yl]but-2-enyl]-5-[(dimethylamino)methyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide.
Molecular Properties
| Compound Name | N-[1-[(E)-4-[5-carbamoyl-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-7-(3-hydroxypropoxy)benzimidazol-1-yl]but-2-enyl]-5-[(dimethylamino)methyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide |
|---|---|
| PubChem CID | 155786918 |
| Molecular Formula | C40H48N10O8 |
| Molecular Weight | 796.89 g/mol |
| Exact Mass | 796.37 |
| IUPAC Name | N-[1-[(E)-4-[5-carbamoyl-2-[(4-ethyl-2-methyl-1,3-oxazole-5-carbonyl)amino]-7-(3-hydroxypropoxy)benzimidazol-1-yl]but-2-enyl]-5-[(dimethylamino)methyl]-7-methoxybenzimidazol-2-yl]-4-ethyl-2-methyl-1,3-oxazole-5-carboxamide |
| SMILES | CCc1nc(C)oc1C(=O)Nc1nc2cc(CN(C)C)cc(OC)c2n1C/C=C/Cn1c(NC(=O)c2oc(C)nc2CC)nc2cc(C(N)=O)cc(OCCCO)c21 |
| InChI | InChI=1S/C40H48N10O8/c1-8-26-34(57-22(3)42-26)37(53)46-39-44-28-17-24(21-48(5)6)18-30(55-7)32(28)49(39)13-10-11-14-50-33-29(19-25(36(41)52)20-31(33)56-16-12-15-51)45-40(50)47-38(54)35-27(9-2)43-23(4)58-35/h10-11,17-20,51H,8-9,12-16,21H2,1-7H3,(H2,41,52)(H,44,46,53)(H,45,47,54)/b11-10+ |
| InChIKey | LCNFQNNNMDXLGQ-ZHACJKMWSA-N |
| XLogP | 4.79 |
| TPSA | 230.92 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 796.89 |
| LogP ≤ 5 | 4.79 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 15 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155786918 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.